BTKi
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BTKi, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study [Phase 2]